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H
eme proteins are one of the largest classes of metalloproteins. Their functions range from electron transfer to storage, transportation, and sensing of small molecules, such as O 2 , NO, and CO, and to catalysis, such as oxygenation, oxidation, and reduction (1) (2) (3) . One of the most important questions in the chemistry and biology of heme proteins is how the same heme prosthetic group is used by different heme proteins to achieve structural and functional diversity (1) (2) (3) (4) (5) . For example, myoglobins (Mb) and hemoglobins bind O 2 reversibly and are O 2 carriers (6, 7). Cytochrome P450 (P450; refs. [8] [9] [10] and heme oxygenase (HO; refs. 11-14) not only bind O 2 , but also activate O 2 to transfer the oxygen atom to other organic molecules or to the heme prosthetic group, respectively. Finally, heme-containing oxidases bind, activate , and reduce O 2 to water (15) (16) (17) (18) (19) . In the process, they convert the chemical energy in the reaction into a proton gradient that in turn drives the synthesis of ATP, a universal energy source for biological systems.
Heme-copper oxidases (HCOs) are a superfamily of terminal oxidases in the respiratory chains of both eukaryotic mitochondria and bacteria (15) (16) (17) (18) (19) . They all contain a heteronuclear heme-copper center ( Fig. 1) where O 2 binding, activation, and reduction to water occur (20) (21) (22) (23) (24) . The hemecopper center is unique in that it contains not only a heme with a proximal histidine ligand, commonly found in other heme proteins, such as Mb and HO, but also a copper center (called Cu B ) that is coordinated to three histidines and is within Ϸ5 Å of the heme iron center. Understanding the structure and function of this heme-copper center has been the focus of intense biochemical (25) (26) (27) (28) , spectroscopic (29) (30) (31) (32) (33) (34) (35) (36) ), x-ray crystallographic (20) (21) (22) (23) (24) , and biomimetic modeling studies (37) (38) (39) (40) (41) (42) (43) (44) (45) .
Whereas the above studies have made tremendous progress toward understanding the role of the heme-copper center, several important questions about the heme-copper center still remain. For example, what is the exact role of the Cu B center in O 2 binding and activation? How is O 2 reduction at the heme-copper center coupled to proton delivery or uptake? To answer the first question, studies on Cu B -deleted HCO (46) (47) (48) and HCO variants containing mutations of the histidines to the Cu B center (28, 49, 50) indicated that removing or perturbing of the Cu B center resulted in substantial changes in the heme-copper center and little oxidase activity. Whereas the results clearly showed that Cu B is important for HCO activity, the exact role of Cu B remained to be defined. Interestingly, recent studies on synthetic models of HCO suggest that, when using an electrode to provide a source of electrons, Cu B is not required for OOO bond cleavage and affects HCO activity only through a nonredox mechanism (44, 45) .
To answer the question of proton coupling to O 2 reduction, biochemical and biophysical studies of HCO and its variants have shown that proton coupling to O 2 reduction is critical for the HCO activity (15-19, 51, 52) . It is known that the O 2 reduction to water consumes four protons, four electrons, and one O 2 , which is also coupled to pumping four additional protons across the membrane (15) (16) (17) (18) (19) . Progress has been made on the mechanistic study of HCOs, including biochemical and biophysical characterization of the P (''peroxy'') and F (ferryl) intermediates. The structure of the F-intermediate is agreed
to be a ferryl [Fe(IV)AO] species similar to compound II in peroxidases; the P-intermediate was so named because it was believed to be an end-on peroxy [Fe(III)OO 2 2Ϫ ] species. However, several spectroscopic investigations implied that the OOO bond had already been cleaved at this step (53) (54) (55) (56) (57) (58) (59) . Strong evidence supporting this theory has been shown recently in labeling experiments that demonstrated the exchange of H 2 18 O into solution on the formation of the P-intermediate from 18 O 2 (60) . To follow up these findings, further research is needed to fully understand the reaction mechanism in HCO and the exact step in which the reduction is coupled to proton consumption and pumping.
To contribute to the understanding of the roles of Cu B and protons in HCO, we and others made model HCO proteins by engineering a Cu B center in yeast cytochrome c peroxidase (61, 62) and sperm whale Mb (ref. 63 ; Fig. 1 
Materials and Methods
Protein Purification. A sperm whale Mb variant, Cu B Mb, was expressed and purified as described (63) . To remove any metal ion contamination, the protein sample was treated with 30 mM EDTA and passed down a size exclusion column (Sephadex G-25) equilibrated with 20 mM Tris and 100 mM NaCl buffer at pH 8 before it was passed through another size exclusion column equilibrated with 20 mM Tris buffer alone.
Electronic Absorption (UV-vis) Characterization. UV-vis spectra were obtained by using a Hewlett-Packard 8453 spectrometer. The samples were in 20 mM Tris buffer at pH 8. The experimental temperature was set to 25°C by a circulating water bath equipped with a Polysciences 9510 digital temperature controller.
Kinetic Study of O2 Reduction. For the kinetic studies, the metCu B Mb (6 M) was mixed with 6 mM sodium ascorbate and 0.6 mM N,N,NЈ,NЈ-tetramethyl-p-phenylenediamine (TMPD) in 20 mM Tris buffer at pH 8. The reaction was initiated by adding 12 M (2 equivalents) of CuSO 4 . Two equivalents of Cu(II) was used in the experiment to saturate the copperbinding site in Cu B Mb, as the K D Ϸ 9 M (63). Addition of one equivalent of CuSO 4 resulted in the same spectral changes and at reduced rates (data not shown). In addition to copper ions, 340 units of bovine liver catalase were also added to the reaction mixture to prevent exogenous hydrogen peroxide formation. In separate experiments, two equivalents of Ag(I)NO 3 or ZnSO 4 was added in place of copper to investigate the effect of different metal ions. In air-saturated buffer, the O 2 concentration was measured to be Ϸ225 M by using a Model 53 Oxygen Meter (YSI, Yellow Springs, OH). The spectral changes were monitored at 418 nm and 678 nm with the kinetic software provided with the UV-vis spectrometer. The rates were calculated by fitting change in absorbance vs. time to a double exponential equation of formation (Eq. 1) or decay (Eq. 2).
Kinetic Study of H2O2 Reaction. Fig. 2A Inset) . This spectrum is nearly identical to that of deoxy-WTMb, indicating that mutations in Cu B Mb did not cause major structural changes around the heme center. When the deoxy-Cu B Mb is exposed to air, the resulting spectrum of the reduced protein represents a mixture of sixcoordinate oxy-Cu B Mb, with a Soret band at 418 nm and fivecoordinate deoxy-Cu B Mb, with a shoulder at 434 nm (Fig.  2 A) . This finding is in contrast to the WTMb, which is almost exclusively in the oxy form under the same conditions. These results suggest that the two introduced histidine mutations in the distal pocket of Cu B Mb, when not binding to any metal ions, lowered the O 2 binding affinity of the heme in Cu B Mb relative to that in WTMb. This suggestion is supported by measuring the spectrum of deoxy-Cu B Mb exposed to O 2 -saturated buffer; the ratio of oxy-Cu B Mb over deoxy-Cu B Mb increased from 1.2 in air-saturated buffer to 2.0 in O 2 -saturated buffer (Fig. 2 A) . Interestingly, addition of 1-4 equivalents of Ag(I) in air-saturated buffer resulted in a decrease of the 434 nm shoulder and increases of absorptions at 418, 545, and 576 nm (Fig. 2B) . The final spectrum is identical to that of the oxy-WTMb. This result suggests that, binding of Ag(I), a re-dox-inactive mimic of Cu(I), enhances the O 2 -binding affinity of Cu B Mb.
Kinetic Study of O2 Reduction by CuBMb. The study was carried out in the presence of excess TMPD and ascorbate. In addition, 340 units of catalase were also added to prevent exogenous peroxide from reacting with heme in Cu B Mb (66) . On addition of CuSO 4 to the oxy-Cu B Mb, the Soret band at 418 nm decreased and shifted toward 408 nm (Fig. 3A) . The intensities of the 545-and 586-nm absorption bands typical of the oxy-Cu B Mb also decreased. The decay of these absorption bands is accompanied by formation of bands at 622 and 678 nm. The band at 678 nm is indicative of the presence of verdoheme, as observed in heme oxygenase and its variants (11) (12) (13) . This assignment is confirmed by addition of 20% pyridine to the reaction mixture at Ϸ100 s and observation of the resulting UV-vis spectrum (see Fig. 3A Inset) , which is identical to the pyridine derivative of verdoheme (67, 68) . Furthermore, when the reaction is extended to Ϸ 600 s, the 678-nm band decreased with an increase of the 622-nm band. The final spectrum (e.g., at 464 s, Fig. 3A) is quite similar to the CO-bound verdoheme of oxygenase and its variants (67) (68) (69) . Finally, the presence of verdoheme in the reaction mixture was confirmed by electrospray mass spectrometry. Before copper addition, the observed spectrum was that of the unmodified heme (m͞z ϭ 616). Nine minutes after Cu addition, a new species appeared with molar mass (m͞z ϭ 619) and isotopic distribution consistent with verdoheme (Fig. 4) .
The decay of the Soret band at 418 nm exhibits biphasic behavior (Fig. 3B) . It can be fit to a double exponential equation, with k 1 ϭ 0.028 s
Ϫ1
and k 2 ϭ 0.0083 s
. However, the increase in 678 nm exhibits single phase kinetics (if it was fit to a double exponential equation, the reaction rates with k 1 ϭ 0.028 s Ϫ1 and k 2 ϭ 0.028 s Ϫ1 were obtained). We attributed the first phase of the biphasic kinetics at 418 nm as heme degradation to form verdoheme (at k 1 ϭ 0.028 s
, which is identical to the rate of verdoheme formation measured at 678 nm), and second phase as heme autooxidation (at k 2 ϭ 0.0083 s
; Fig. 3B ). These results suggest that the copper ion in Cu B Mb facilitates reduction of O 2 , which then converts the heme in Cu B Mb to verdoheme. CO is a product of heme conversion to verdoheme and it can bind to verdoheme after it is produced (11) (12) (13) (14) . Initially both verdoheme (which absorbs at 678 nm) and CO-bound verdoheme (which absorbs at 622 nm) form from the reaction. On further reaction, most of the verdoheme was converted to CO-bound verdoheme.
To further probe the role of the Cu B center in O 2 reduction, the following control experiments were performed. First, under identical conditions to the above reaction of Cu B Mb shown in Fig. 3A , oxy-WTMb did not show any spectral changes, even in the presence of the same concentration of copper ions (data not shown; see Discussion). Second, no reaction in Cu B Mb was observed in the absence of copper ions (Fig. 3B) . Finally, when Zn(II) or Ag(I) was added to the reaction instead of Cu(II) ions, no spectral changes were observed in Cu B Mb (Fig. 3B) . These results strongly suggest that the Cu B center plays a critical role in O 2 reduction in Cu B Mb. Kinetic Study of H2O2 Reaction with Met-CuBMb. When 1 equivalent of H 2 O 2 was added to met-Cu B Mb, the met-Cu B Mb spectrum (with absorptions at 408, 508, and 628 nm) was rapidly converted to a spectrum (with absorptions at 419, 546, and 581 nm; see Fig. 5A ) that is almost identical to that of Compound II of WTMb. This result indicates that reaction of H 2 O 2 with met-Cu B Mb produces ferryl-heme instead of verdoheme. This reaction requires fewer equivalents of H 2 O 2 than WTMb (Fig. 5B) for completion, and the reaction rate is Ϸ10-fold faster than that of WTMb (WTMb, k obs ϭ 0.018 s 
Discussion
The heme-copper center shown in Fig. 1 is at the heart of HCO. It catalyzes reduction of O 2 to water, which is coupled to proton delivery and uptake. By using a model HCO protein in Mb, we seek to address two important questions related to the center: the role of Cu B in O 2 binding and reduction, and the role of protons in O 2 reduction.
The Role of CuB in O2 Binding and Reduction. As shown in Fig.  2 A, the spectra of deoxy-WTMb and -Cu B Mb are almost identical. This result, combined with those from the UV-vis and electron paramagnetic resonance study of met-Cu B Mb (63) , indicates that the L29H͞F43H mutations in Cu B Mb did not cause gross changes of the structure around the heme center. However, the mutations did lower the O 2 -binding affinity of copper-free Cu B Mb because, unlike WTMb, when the deoxy-Cu B Mb was exposed to air, it does not convert to oxy-Cu B Mb completely (Fig. 2B) . The shoulder at 434 nm indicates that some deoxy-Cu B Mb remains in the solution and does not bind O 2 . However, addition of Ag(I) increases the O 2 binding affinity of Cu B Mb by full conversion to oxyCu B Mb in air (Fig. 2B) . Together, these results strongly suggest that the Cu B center is important for O 2 binding and contributes to the increased O 2 binding affinity of the protein.
It has been known for a long time that Mb, on exposure to O 2 and a reductant, such as ascorbate, can reduce O 2 , which then can induce heme degradation to verdoheme and Fe(III)-biliverdin, products observed in heme oxygenase reactions (70) (71) (72) . This process in Mb is termed coupled oxidation. We have shown previously that this process can be inhibited completely with subequivalent amounts of catalase, indicating that, unlike in HO, exogenous peroxides must be involved in coupled oxidation (66) . Therefore, in the presence of catalase, WTMb is incapable of O 2 reduction even though excess amounts of Cu(II) ions and reductants, such as ascorbate and TMPD are added. No O 2 reduction is observed either when the Cu B center in Cu B Mb is empty or when it is occupied by redox-inactive Zn(II) or Ag(I) (Fig. 3B) .
The clear evidence for the role of Cu B in O 2 reduction is shown in Fig. 3A . Even in the presence of catalase, addition of Cu(II) in the presence of excess reductants (ascorbate and TMPD) resulted in a rapid change of UV-vis spectra indicative of formation of verdoheme. The verdoheme formation was confirmed by comparison of its pyridine and CO derivatives to those in HO, and by electrospray mass spectrometry. Combined with control experiments using WTMb and cop- per-free and redox-inactive Zn(II) and Ag(I) derivatives of Cu B Mb, the results provide strong evidence that the Cu B center is essential in O 2 reduction.
Because the reaction products are similar to the heme degradation products in HO, O 2 reduction in Cu B Mb must go through the same peroxy-heme intermediates as in  Fig. 6 ). Peroxy-heme has also been proposed to be a key intermediate in oxidase, although its presence has never been observed in HCO (15) (16) (17) (18) (19) . This result is understandable because peroxy-heme in general is quite unstable and can be observed only in limited cases, such as through ␥-irradiation or radiolytic reduction of the corresponding oxy-heme proteins (73) (74) (75) (76) .
Whereas we have shown that Cu B center is responsible for increased O 2 affinity, and is essential for O 2 reduction and formation of the same peroxy-heme intermediate as in HCO, a surprise finding from this study is that, instead of going through the formation of ferryl species as in the peroxy and ferryl states of the HCO pathway, the peroxy-heme intermediate in Cu B Mb attacks heme and follows the HO reaction pathway (Fig. 6 ). We will address this issue in the next section.
The Role of Protons in O2 Reduction. In the previous studies (4, 72, 77) , Mb has been used as a model for other O 2 -binding heme proteins, such as HO, P450, and HCO. These proteins represent distinct levels of the interaction of dioxygen with the proteins. Myoglobin reversibly binds but does not reduce dioxygen, whereas HO, P450, and HCO reduce dioxygen by 2e Ϫ , 2e Ϫ , and 4e Ϫ , respectively. Interestingly, the first step in the catalytic cycle of HO, P450, and HCO is proposed to be the two-electron reduction of dioxygen to a peroxide intermediate. In HO, this intermediate leads to the formation of verdoheme and then biliverdin (11) (12) (13) (14) . In P450 and HCO, this intermediate leads to formation of ferryl heme and then substrate oxidation (in the case of P450; refs. 8-10) or further 2e Ϫ reduction of ferryl heme to water (in the case of HCO; refs. [15] [16] [17] [18] [19] . A critical question regarding these proteins is, given the same putative peroxy-heme intermediate, why those different proteins perform different reactions.
A clue to the above question is emerging. Several elegant biochemical and biophysical studies on P450, HO, and their variants (69, 73, 74, (78) (79) (80) (81) (82) (83) (84) showed that the presence of a hydrogen bonding network in the distal pocket of the heme protein, through bridging water and hydrophilic or charged residues (such as Thr in P450 or Asp in HO), is essential for delivery of proton(s) to the peroxy-heme so that the proteins can undergo either heme degradation to form verdoheme and biliverdin (HO) or ferryl-heme formation for substrate oxidation (P450). More importantly, Fujii et al. (69) proposed that one more proton is required for P450 to form ferryl heme than HO. Other studies also showed that, once ferryl-heme is formed, it is no longer capable of heme degradation (11) (12) (13) 67) .
In this study, we have shown that Mb can reduce O 2 to the putative peroxy-heme, as long as a copper ion is present in the engineered Cu B center of the Cu B Mb. The reason that the peroxy-heme in Cu B Mb undergoes heme degradation like HO rather than ferryl-heme formation like HCO is that the engineered first-generation Cu B Mb may not have the elaborate hydrogen bonding network found in HCO or P450 to deliver the extra proton to a precise location. To support this proposal, we have carried out a reaction of H 2 O 2 with metCu B Mb, because 2e Ϫ reduction of O 2 produces a species equivalent in oxidation state to H 2 O 2 . This so-called ''peroxide-shunt'' reaction is known in HO, P450, and HCO (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . When H 2 O 2 was reacted with met-Cu B Mb, a ferryl-heme was observed instead of verdoheme (Fig. 5A) . This result suggests that the extra protons brought into the Cu B Mb active site by the H 2 O 2 may allow the Cu B Mb to switch from the HO reaction pathway into the P450 and HCO pathway. Therefore, proton delivery through a hydrogen bonding network in the distal heme pocket is important not only for HO and P450, but also for HCO.
Interestingly, peroxy-porphyrin was also observed in synthetic models of HCO (42, 43) . However, no heme degradation was observed in the model systems. The reason may be that the meso-positions of the porphyrins in the model systems were blocked by substitution with aromatic molecules, a feature not present in native HCO proteins. Alternatively, the electronic structural and redox properties of the porphyrin in the model systems may be tuned to resist heme degradation. Furthermore, in contrast to the important role played by the Cu B in O 2 reduction (Fig. 3) , Cu B seems to play only a minor role in the H 2 O 2 reaction with met-Cu B Mb (Fig. 5) , because Zn(II) and Ag(I) can promote ferryl-heme formation, even though at a slower rate. This result is understandable because, in the peroxide-shunt pathway, Cu(II) plays no redox role. Previous studies have shown that even histidine, when positioned in the right position, can enhance peroxidase activity of Mb (77, 85, 86) .
In summary, we have shown that the engineered Cu B center in Cu B Mb is responsible for the increased O 2 binding affinity and for efficient O 2 reduction to the putative peroxyheme. Furthermore, proton delivery coupled to the O 2 reduction is necessary to avoid a HO reaction pathway that would lead to heme degradation and loss of HCO activity. One of salient features of the catalytic site in HCO is the presence of a tyrosine that is covalently linked to one of the histidine ligands to the Cu B center (20) (21) (22) (23) (24) . This His-Tyr linkage may play a role in electron and proton transfers in HCO. The next step involves introducing an active-site tyrosine into Cu B Mb to model the role of tyrosine in the reduction of O 2 by HCO.
